设为首页 加入收藏 中文版 English

The current position: Home>Technology

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged ... [more]
Technology

Safety

Originally the immune system has not been developed in our stem cells, so there is no immunorejection antigen; according to the feedback of over 10,000 injections, no immunorejection has been found. And our cells will be examined doubly by PLA 461 Hospital and Jilin Liver and Gallbladder Diseases Hospital

上一篇:Authoritativeness

下一篇:Effectiveness

版权所有© 吉林省中科生物工程有限公司 吉ICP备12000258号
客服
live chat